Target and Hit Assessment — WuXi Biologics

At WuXi Biologics, we build each target and hit assessment engagement around context. The right plan depends on what has already been learned, what remains uncertain, which inputs are ready, and how the results will influence the next decision. Our team brings those factors together early so the work has a clear purpose, an agreed path, and deliverables matched to your program.

Our target and hit assessment capabilities

We approach target and hit assessment by defining success before the first activity starts. We use early scoping to build a sharper request, review the proposed approach, and agree what a decision-ready result will look like. The goal is to find and validate tractable starting points with evidence strong enough to guide investment. Our project plan explains how the work will produce evidence for which hits or candidates should advance, be redesigned, or stop, including what will happen if results fall outside expectations. Early alignment on inputs, assumptions, responsibilities, and review gates is often the difference between useful evidence and an expensive activity report. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. We are a leading global contract research, development, and manufacturing organization (CRDMO) for biologics. They offer end-to-end solutions for antibodies, bispecifics, antibody-drug conjugates, fusion proteins, enzymes, and vaccines using both mammalian and microbial expression platforms, supporting clients from discovery through commercial manufacturing at scale. Core capabilities include flow cytometry, immunoassays, cell sorting, and bioanalytical services for biologics characterization and quality control. This context helps establish potential fit. Final selection should depend on project-specific evidence: the proposed scientific lead, relevant examples, methods, capacity, quality status, and timeline. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

• Assay format, controls, library or modality, and throughput.

How we shape the scope

During scoping, we work through the objective, acceptance criteria, dependencies, and potential decision points in plain language. We also identify assumptions that need to be tested before they become schedule or budget problems. The resulting plan defines responsibilities on both sides, shows where reviews will occur, and makes clear how changes in inputs or findings will be handled. This creates a shared operating picture without locking the project into details that should remain flexible.

Working with WuXi Biologics

Our team treats communication as part of the technical service. We establish contacts, review points, and escalation paths at the outset, then use them to keep decisions moving. Interim conversations distinguish confirmed findings from working interpretations and unresolved questions. That separation is important: it lets the program team act with appropriate confidence while giving specialists space to investigate observations that require more context.

Deliverables built for the next decision

Outputs are planned for the people who will use them next. At kickoff, we agree on the required files, summaries, documentation, and review process rather than assuming a standard package will fit every program. Our final review connects the deliverables back to the original objective and highlights material observations, limitations within the performed scope, and follow-up questions. This makes the handoff more useful for internal review, partner discussions, and subsequent development planning.

Planning your target and hit assessment project with WuXi Biologics

A productive first discussion about target and hit assessment usually includes the question to be answered, current program context, available materials or data, target timing, and required outputs. With that foundation, we can identify gaps, explain practical options, and shape a proposal that clearly states activities, inputs, responsibilities, milestones, deliverables, assumptions, and the factors most likely to change scope.